Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2021, Vol. 26 ›› Issue (1): 1-9.doi: 10.12092/j.issn.1009-2501.2021.01.001

    Next Articles

Tangshen formula promotes cellular cholesterol efflux in HG-induced mTECs by suppression of TGF-β1/Smad3 pathway

LIU Peng1, ZHAO Hailing2, SHEN Zhengri1, WANG Chen1, WANG Yun1, QIU Xinping1, LI Ping2   

  1. 1 Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital, Beijing 101300, China
  • Received:2020-07-29 Revised:2020-12-02 Online:2021-01-26 Published:2021-02-01

Abstract: AIM: To observe the effect of Tangshen formula (TSF) treatment on TGF-β1/Smad3 pathway and cellular cholesterol efflux and explore its potential mechanism in HG-induced mouse tubular epithelial cells (mTECs). METHODS: After 25 mmol/L high glucose induced mTECs, TSF and Smad3 inhibitor SIS3 were given to intervene respectively. The lipid content in the cells was detected by ELISA kit; TGF-β1/Smad3 pathway and PGC-1α, LXR, ABCA1, ABCG1 were detected by Western blot and real-time PCR. RESULTS: TSF diminished the levels of TC, TG, LDL-C and increased the levels of HDL-C in HG-induced mTECs. Western blot and real-time PCR analysis showed that expression levels of TGF-β1, Smad3, Collagen Ⅰ and Fibronectin were significantly downregulated in the HG-induced mTECs with TSF and SIS3 treatment. And PGC-1α, LXR, ABCA1, ABCG1 expression levels were significantly upregulated in the HG-induced mTECs with TSF and SIS3 treatment. CONCLUSION: TSF can promote the cellular cholesterol efflux in HG-induced mTECs vis suppression of TGF-β1/Smad3 pathway. 

Key words: Tangshen formula, diabetic nephropathy, TGF-β1/Smad3 pathway, cellular cholesterol efflux, SIS3 (Smad3 inhibitor)

CLC Number: